Triamcinolone Acetonide/Hyaluronic acid

曲安奈德/透明质酸

Report date: 2025/11/14 14:16:41

Base Information

Drug NameTriamcinolone Acetonide/Hyaluronic acid
Drug Alias NameTriamcinolone acetonide+Hyaluronic acidHydros-TA
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsHyaluronic acid replacements
TargetsGlucocorticoid receptorHyaluronic acid
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaAustraliaNetherlands Antilles
CombinationsYes Triamcinolone AcetonideSodium Hyaluronate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKalvista Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCarbylan Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A